Kiniksa Pharmaceuticals 8-K Filing on Shareholder Votes
Ticker: KNSA · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1730430
| Field | Detail |
|---|---|
| Company | Kiniksa Pharmaceuticals International, PLC (KNSA) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
TL;DR
Kiniksa Pharma filed an 8-K for shareholder votes. All good.
AI Summary
Kiniksa Pharmaceuticals International, plc filed an 8-K on June 3, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporate structure and its principal executive offices located at 23 Old Bond Street, Floor 3, London, England.
Why It Matters
This filing indicates that Kiniksa Pharmaceuticals International, plc is engaging in formal processes involving its shareholders, which could relate to corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Kiniksa Pharmaceuticals International, plc (company) — Registrant
- June 3, 2025 (date) — Date of earliest event reported
- 23 Old Bond Street, Floor 3, London, England (location) — Address of principal executive offices
FAQ
What specific matters were submitted to a vote of Kiniksa Pharmaceuticals International, plc's security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact matters in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 3, 2025.
What is the principal executive office address for Kiniksa Pharmaceuticals International, plc?
The principal executive offices are located at 23 Old Bond Street, Floor 3, London, England, W1S 4PZ.
What is the SEC file number for Kiniksa Pharmaceuticals International, plc?
The SEC file number is 001-38492.
What is the former name of Kiniksa Pharmaceuticals International, plc?
The former company name was Kiniksa Pharmaceuticals, Ltd., with a date of name change on 20180205.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Kiniksa Pharmaceuticals International, plc (KNSA).